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Abstract
The fatty acid de novo synthesized in mammary gland is mainly  catalyzed by fatty acid 
synthase (FASN) and acetyl CoA carboxylase (ACC), including all the short- and medium-
chain fatty acid and half part of the palmitate in ruminants. However, the synthesis mecha-
nism of medium-chain fatty acid among different species is different. In non-ruminants, a 
tissue-specific enzyme thioesterase II (TE II) can interact with TE I, which is a part of FASN, 
and terminate the elongation of fatty acids at about 10 carbons. However, in ruminants’ 
mammary-gland acetyl/malonyl-CoA transferase (MAT) is predicted to be involved in 
the termination of medium-chain fatty acid without the presence of (TE II). A more exact 
understanding about the mechanism of synthesis of medium-chain fatty acid in different 
species is still unclear. This review gives the research development of synthesis mechanism 
of medium-chain fatty acid in mammary gland among different species.
Keywords: mammary gland, medium-chain fatty acid, FASN, ruminants
1. FASN and fatty acid synthesis
The composition of milk fatty acid varies greatly among different species. Long-chain fatty 
acid is the most abundant fatty acid (C14-C18) in guinea pigs, medium-chain fatty acid takes 
a large part of medium-chain fatty acid (C8-C10), and long-chain and short-chain (C4-C6) 
fatty acids are the most abundant in cow’s milk [1]; however, in goat milk all carbon-chain 
fatty acids are observed including short-chain, medium-chain, and long-chain fatty acids [2]. 
The short-chain and medium-chain fatty acids are mainly de novo synthesized in mammary 
gland [3–5].
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The synthesis of fatty acid in mammary gland is mainly catalyzed by fatty acid syn thase (FASN) 
and acetyl CoA carboxylase (ACC). In mammalian cells, the functional form of FASN is a 
homodimer (MW ~540,000 Da) [6]. FASN is composed of seven domains, including b-ketoacyl 
synthase (KS), acetyl/malonyl-CoA transferase (MAT), b-hydroxyacyl dehydratase (DH), enoyl 
reductase (ER), b-ketoacyl reductase (KR), acyl-carrier protein (ACP), and thioesterase I (TE I) 
(Figure 1). The core region between the DH and ER domains has no catalytic activity. At first, 
the acyl moiety of acetyl-CoA (initiation substrate) is transferred to the ACP catalyzed by MAT 
to generate malonyl-CoA (elongation substrate). And then, the acyl moiety is momentarily 
transferred to KS, and transacylation of malonyl-CoA is catalyzed by MAT to ACP. Acetoacetyl-
ACP is then generated with decarboxylative condensation catalyzed by KS. This process fol-
lows catalyzation by KR and DH, which are responsible for the NADPH-dependent reduction 
of the b-carbon, and the dehydration of b-hydroxyacyl-ACP to a,b-enoyl, respectively. And 
then, by the catalyzation of ER, a four-carbon acyl chain is produced from NADPH-dependent 
reduction of the enoyl. The subsequent elongation cycles are performed with the malonyl-CoA 
as two-carbon units. Lastly, TE I is responsible for the release of fatty acid, with a length of 16 
carbons, from ACP [6].
Figure 1. The structure of FASN gene and the fatty acid synthesis cycle. (a) The domain structure of FASN and the active 
site residues. (b) De novo fatty acid synthesis cycle catalyzed by domains of FASN.
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FASN is the crucial enzyme for milk fat synthesis [7]. It plays an important role in the regula-
tion of energy metabolism, cell membrane formation, signaling pathway regulation, and epi-
genetics [8]. By comparing the sequences of FASN in different species, including goat, sheep, 
cattle, human, chicken, and rats, FASN genes contain 42 exons in cattle and 43 exons in human 
and mice, and so on [9] (Figure 2).
FASN is also important for the regulation of the genes related to fatty acid synthesis in mam-
mary gland. The inhibition of FASN with orlistat, a natural inhibitor of FASN, suppressed 
the expression of ACC, lipoprotein lipase (LPL), and heart-type fatty acid-binding protein 
(H-FABP) [10]. The inhibition of FASN in mammary cells by C75-mediated interference, a syn-
thetic inhibitor of FASN activity, and short hairpin RNA-mediated interference significantly 
suppressed the deposition of triglyceride, decreased the expression of glycerol-3-phosphate 
acyltransferase (GPAT), 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT6), and diac-
ylglycerol acyltransferase (DGAT2), which are important for cellular triglyceride synthesis. 
The inhibition of FASN also enhanced the expression of adipose triglyceride lipase (ATGL) 
and hormone-sensitive lipase (HSL), both of which are crucial for lipolysis. This is consistent 
with the markedly lower expression of genes related to lipid-droplet formation and secretion 
(hormone-sensitive lipase, TIP47; adipose differentiation-related protein, ADFP; xanthine 
oxidoreductase, XDH; butyrophilin 1A1, BTN1A1) [10].
Despite the effect of FASN inhibition on gene expression and lipid metabolism, the exact mecha-
nism underlying the effect remains unclear. As a terminal enzyme for de novo fatty acid synthe-
sis, previous studies indicated that FASN could help control lipid metabolism through indirect, 
hence, secondary effects. For instance, FASN could be involved in the control of fatty acid syn-
thesis and oxidation through a direct effect on the concentration of malonyl-CoA, which was 
shown to help control lipid metabolism through the inhibition (allosteric) of β-oxidation by car-
nitine palmitoyltransferase 1 (CPT1) [11, 12]. In addition, FASN also helps generate ligands for 
transcription regulators, including peroxisome proliferator-activated receptors (PPARs) [13, 14], 
sterol-regulatory element-binding protein 1 (SREBP1), hepatocyte nuclear factor 4a (HNF4α), 
NF-E2-related factor-2 (NRF2), and Toll-like receptor 4 (TLR4) [14], all of which are important for 
lipid metabolism regulation. FASN also may affect protein activity indirectly, for example, endo-
thelial nitric-oxide synthase, through palmitoylation [15]. Lastly, FASN may interact directly with 
caveolin-1 and lipid raft, which was involved in lipid secretion [16, 17]. However, the exact mech-
anism of how FASN affects the expression of genes related to milk fat synthesis remains unclear.
Figure 2. Prediction of exons and functional domains of FASN cloned from the goat mammary gland. Goat FASN gene 
includes 42 exons represented by seven function domains, in which three catalytic domains in the N-terminal section 
(KS, MAT, and DH) were separated by a core region from four C-terminal domains (ER, KR, ACP, and TE I). The sheep 
FASN gene contains 41 exons (XM 004013447).
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2. The synthesis of medium-chain fatty acids in non-ruminants
The activity of hydrolase was necessary for the control of the length of the fatty acids produced 
by FASN with the main product of FASN being C16 palmitate. The thioesterase domain, TE I, 
catalyzes the termination step by hydrolyzing the thioester bond between palmitate and the 
4ʹ-phosphopantetheine moiety of the acyl-carrier protein (ACP) domain. Orlistat is a natural 
inhibitor of FASN, which was captured in the active sites of two thioesterase molecules as a 
stable acyl-enzyme intermediate and as the hydrolyzed product. The release of the thioester-
ase from FASN by limited proteolysis, however, results in the production of fatty acids con-
taining 20–22 carbons [18]. Thus, the thioesterase domain is essential in regulating the length 
of the fatty acid chain.
Carey et al. [4, 19] purified the FASN protein from rabbit, mouse, and pig; the results showed 
that they just synthesized long-chain and short-chain fatty acids but not medium-chain fatty 
acids. However, with the help of TE II, FASN can produce all kinds of fatty acids, including 
C8, C10, C12, and so on [20, 21]. The medium-chain fatty acids synthesized de novo can be 
incorporated directly into triacylglycerol without the need of an activation step [22].
TE II is a tissue-specific enzyme independent of FASN. TE II can interact with TE I, which is a 
part of FASN, and terminate the elongation of fatty acids at about 10 carbons [23]. Decanoyl-
CoA and decanoyl-pantetheine are the best substrates for TE II [24]. Ser101 and His237 of TE 
II are critical for the interaction. Asp236 of TE II enhances but is not essential for the reactivity 
of Ser101 and His237. For Leu262, it is involved in the interaction of TE II with TE I [23]. The 
interaction between TE II and FASN is stimulated by polyethylene glycol and suppressed by 
high concentrates of salt. Orlistat is a natural inhibitor and has a significant inhibition effect 
on FASN activity by curbing the binding of TE domain between FASN subunits [25]. TE II also 
can interact with P53 and is involved in the cancer development [25].
3. MAT and medium-chain fatty acid synthesis in ruminants
As a tissue-specific enzyme, TE II is only observed in non-ruminants. A similar enzyme is 
not present in goat mammary gland, although octanoic acid, decanoic acid, and dodecanoic 
acid amount to 20 mol% of the fatty acids synthesized in this tissue [26]. By contrast, goat 
mammary-gland fatty acid synthetase is by itself able to synthesize medium-chain fatty acids 
in the presence of the microsomal fraction and substrates for triacylglycerol synthesis [27]. 
Goat mammary-gland fatty acid synthetase exhibits both medium-chain thioesterase [21] and 
transacylase activity [28]. It seems that there are some differences about the activity of FASN 
between goat and other species. By treating the FASN protein of goat FASN with PMSF, an 
inhibitor of TE activity results in the termination of long-chain fatty acid synthesis, but not 
the medium-chain fatty acids. These results showed that there must be another hydrolase 
center in FASN protein. Hansen and Knudsen found that the supplementary of malonyl-CoA 
changed the proportion of medium-chain fatty acids [29]. Considering that the malonyl-CoA 
is transferred into the reaction by MAT activity, it was predicted that MAT may be involved 
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in the synthesis of medium-chain fatty acid. Engese et al. first found that MAT can transfer 
not only C2 but also C4, C6, and C10 fatty acids from CoA [28, 30], although the malonyl-CoA 
showed the strongest affinity with MAT. Supporting the results, the interference of FASN 
reduced the synthesis of C10:0 and C12:0, increased the content of C14:0, but without an effect 
on C16:0 and C18:0, in goat mammary epithelial cells [31]. These literatures indicate that the 
MAT of goat FASN may be responsible for the termination of short- and medium-chain fatty 
acids in mammary gland.
Rangan and Smith cloned the MAT protein from rat, and showed that MAT expressed in 
Escherichia coli, and refolded in vitro as a catalytically active malonyl-/acetyltransferase [32], 
similar as our previous study in goat expressed for goat mammary epithelial cells that the MAT 
domain is capable of folding correctly as an independent protein (unpublished). Replacement 
of the highly conserved residue His-683 with Ala reduced the activity by 99.95%, and the resid-
ual activity was relatively unaffected by diethyl pyrocarbonate. The rate of acylation of the 
active site serine residue was also reduced by several orders of magnitude in the His-683 to Ala 
mutant, indicating that His-683 plays an essential role in catalysis, likely by accepting a proton 
from the active site serine, thus increasing its nucleophilicity. In addition, Ser581 is also impor-
tant for the activity of MAT. The Ser-581 to Ala mutant was completely inactive with either 
substrate. The Ser-581 to Cys mutant, however, retained approximately 1% of the activity of 
the “wild-type” enzyme compared with about 0.05% retained by His-683 to Ala mutation.
Actually, many other stimulants altered the relative content of medium-chain fatty acids. By 
treating the goat FASN with 5.2 mg/mL, albumin increases the content of C10 fatty acids rela-
tive to C12, while 10.4 mg/mL results in four times of C10 than C12 [33]. The supplementary 
of Malonyl-CoA enhances the synthesis of C12, similar as the effect of globin treatment. These 
treatments can only change the relative content among different kinds of medium-chain fatty 
acids, but not alter the total proportion of medium-chain fatty acids relative to long-chain 
fatty acids [33, 34].
The role of MAT is predicted to be critical for the goat medium-chain fatty acid synthesis; how-
ever, there is no direct evidence for the effect of MAT on fatty acid compositions. Although 
several genes have been proved to be involved in the regulation of fatty acid metabolism in 
mammary gland, how the activity of MAT, not for the whole FASN, on medium-chain fatty 
acid synthesis is controlled remains unclear. Recently, our study showed that malonyl-CoA is 
not only the elongation subtract for de novo fatty acid synthesis but also a regulatory for fatty 
acid deposition as triglyceride and fatty acid oxidation by inhibiting the activity of carnitine 
palmitoyl transferase 1 (CPT1), which is important for the transportation of long-chain fatty 
acids from cytoplasm to mitochondria [35]. Thus, it is the controller that directly interacts 
with MAT domain indicating that malonyl-CoA may be the balancer of lipid metabolism. The 
concentration of malonyl-CoA is mainly regulated by the activity of ACC and FASN, both of 
which are the terminates of lipid metabolism regulation. The hypothesis is that malonyl-CoA 
may be the indicator of fatty acid metabolism in mammary gland and may be the main media-
tor for the length of fatty acid responses to the environment around the mammary gland. This 
may be a good point for revealing the mechanism of fatty acid chain length determination in 
the future study.
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